Edwards Lifesciences Corp. Earnings

Edwards Lifesciences Corp.’s revenue jumped 14.67% since last year same period to $1553.1Mn in the Q3 2025. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 1.36% jump in its revenue since last 3-months.

Edwards Lifesciences Corp.’s net profit fell -90.52% since last year same period to $291.1Mn in the Q3 2025. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -11.73% fall in its net profits since last 3-months.

Edwards Lifesciences Corp.’s net profit margin fell -91.73% since last year same period to 18.74% in the Q3 2025. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -12.92% fall in its net profit margins since last 3-months.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.59 - a -5.2% fall from last quarter’s estimates.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current year stand at 0.59.

Edwards Lifesciences Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Edwards Lifesciences Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.